Pharmaceutical raw materials pidotimod API Cas 121808-62-6_Xian Sgonek Biological Technology Co.,Ltd

Pharmaceutical raw materials pidotimod API Cas 121808-62-6

Product Name	Pidotimod Powder
CAS No.	121808-62-6
Purity	99%
Appearance	White Powder
Molecular Formula	C9H12N2O4S
EINECS No.	2017-001-1

Pidotimod is an immunomodulator, is suitable for patients with low immune function in the body and can be used to prevent acute infection, shorten the course of the disease, reduce the severity of the disease, as an adjuvant drug in the acute infection stage.

Item	Standard		Test Results
Identification	A.H-NMR:Comply with the structure		Complies
	B.LC-MS:Comply with the structure		Complies
	C.The IR spectrum of sample should be identical with that of reference standard;		Complies
	D.HPLC-ESI-MS The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.		Complies
Crystallinity	meets the requirements.		Complies
Loss on drying	≤2.0%		0.19%
Heavy metals	≤10 ppm		<10ppm
Water	≤1.0%		0.1%
Sulphated ash	≤0.5%, determined on 1.0 g.		0.009%
Related substances	Unspecified impurities: for each impurity	≤0.10%	<0.10%
	Total Impurity	≤0.5%	0.18%
Purity	≥99.0%		99.7%
Assay	99.0%~101.0% (anhydrous substance).		99.8%
Microbiological Analysis
Total plate count	≤1000cfu/g		Complies
Yeast and Moulds	≤100cfu/g		Complies
E. Coli.	Absent		Negative
Salmonella	Absent		Negative
S.aureus	Absent		Negative
Storage	Preserve in well-closed, light-resistant and airtight containers.		Complies

Pitidomod is mainly used in children with recurrent respiratory infections and urinary tract infections (urinary tract infections). It also has therapeutic effects on chronic bronchitis and viruses. Flu and viral herpes are effective. It can also be used for infections caused by Streptococcus pneumoniae and Escherichia coli, Green bacillus, Proteus.

Pidotimod is a synthetic dipeptide with immunological modulatory activity on both the adaptive and innate immune responses. This compound has been shown to induce dendritic cell maturation and up-regulate the expression of HLA-DR and co-stimulatory molecules CD83 and CD86, which are integral to communication with adaptive immunity cells. Pidotimod has also been shown to stimulate dendritic cells to release pro-inflammatory molecules such as MCP-1 and TNF-α cytokines, and to inhibit thymocyte apoptosis caused by a variety of apoptosis inducing molecules.

Product Name:	Pidotimod	Cas No.:	121808-62-6
Molecular Formula:	C9H12N2O4S	Purity:	99%min
Brand Name:	SGONEK	Certification:	ISO FDA SG COA MSDS

Pharmaceutical raw materials pidotimod API Cas 121808-62-6

Pharmaceutical raw materials pidotimod API Cas 121808-62-6

Contact Us

Product Category

contact us

Name：
E-mail：
Message：